Consensus AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 10:05:06 16/01/2026 pm IST			5-day change	1st Jan Change
14,052.00 ^GBX	+0.19%		+9,784.64%	+10,089.99%

04:08pm	ASTRAZENECA : Buy rating from UBS	ZD
04:06pm	ASTRAZENECA : Deutsche Bank gives a Sell rating	ZD

Evolution of the Average Target: AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

74c2e7c35ada915a1c2347457.mEpE6ENfy8TSCdVNi9dMmYzj2cNojFmrJ9QvZd305NE.8wdxgxItmIqhfJkmweMm4cuFiPtQxQ7iUoFENJqZg6LdCD3edTSbnoNLnA~fceac42d00d9ae167a3f9148b66bf0d2

Analysts' recommendations: AstraZeneca PLC

04:08pm	ASTRAZENECA : Buy rating from UBS	ZD
04:06pm	ASTRAZENECA : Deutsche Bank gives a Sell rating	ZD
03:19pm	BofA cuts British Land; RBC raises Gym Group	AN
15/01	ASTRAZENECA : Barclays reiterates its Buy rating	ZD
15/01	ASTRAZENECA : Gets a Buy rating from JP Morgan	ZD
14/01	Dagens industri Makes No Changes to Its Ten-Year Portfolio	FW
12/01	Stockholm Bullets - New Wave Rises on Upgraded Recommendation	FW
08/01	ASTRAZENECA : Gets a Buy rating from Berenberg	ZD
07/01	ASTRAZENECA : Barclays maintains a Buy rating	ZD
07/01	Berenberg raises Vodafone; Barclays cuts Hikma	AN
06/01	ASTRAZENECA : Buy rating from JP Morgan	ZD
23/12	London's FTSE 100 edges higher as miners rally on record copper prices	RE
22/12	Stockholm Bullets - Viscaria Soars on Buy Recommendation	FW
16/12	ASTRAZENECA : Receives a Sell rating from Deutsche Bank	ZD
08/12	JPMorgan cuts M&G, UBS cuts Trainline	AN
08/12	ASTRAZENECA : JP Morgan remains its Buy rating	ZD
04/12	ASTRAZENECA : Bernstein remains its Buy rating	ZD
04/12	UK stocks rise on boost from industrials and financials	RE
03/12	AstraZeneca Remains Top Pick at Morgan Stanley - BN	FW
01/12	ASTRAZENECA : Jefferies remains its Buy rating	ZD
01/12	AstraZeneca Leads OMXS30 Gains in November	FW
27/11	Morningstar Downgrades AstraZeneca to Sell	MT
25/11	ASTRAZENECA : Gets a Sell rating from Deutsche Bank	ZD
20/11	AlphaValue/Baader Europe Ups AstraZeneca Price Target on Growth Potential	MT
19/11	AstraZeneca benefits from oncology momentum but valuation limits upside

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ASTRAZENECA PLC					+8.8%
	ELI LILLY AND COMPANY					+8.07%
	JOHNSON & JOHNSON					-3.45%
	ABBVIE INC.					+12.85%
	ROCHE HOLDING AG					-1.33%
	NOVARTIS AG					-3.46%
	MERCK & CO., INC.					+2.13%
	NOVO NORDISK A/S					+8.38%
	AMGEN INC.					+0.47%
	GILEAD SCIENCES, INC.					+10.66%
	Average					+4.31%
	Weighted average by Cap.					+4.43%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

187.81USD

Average target price

206.83USD

Spread / Average Target

+10.13%

High Price Target

245.47USD

Spread / Highest target

+30.70%

Low Price Target

147.95USD

Spread / Lowest Target

-21.22%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BARCLAYS	James Gordon
JPMORGAN	Richard Vosser
BERENBERG	Luisa Hector
BERNSTEIN RESEARCH	Justin Smith
JEFFERIES
Morningstar
alphavalue	Abhishek Raval
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
DZ BANK	Elmar Kraus
GOLDMAN SACHS	Rajan Sharma
UBS	Matthew Weston
BNP Paribas
Svenska Handelsbanken
Berenberg Bank
BNP Paribas Exane
AlphaValue/Baader Europe
Morgan Stanley
Carnegie Group
Intron Health
Deutsche Bank Securities
Nordea Bank
HSBC
Stifel Nicolaus
Jefferies & Co.
Bernstein
B. Riley
RBC Capital Markets
BMO Capital
CREDIT SUISSE	Dominic Lunn
Argus
Bank of America Securities/Merrill Lynch
Danske Bank Group
Kepler Capital Markets
Kepler Cheuvreux
DEUTSCHE BANK	Emmanuel Papadakis
SVB Leerink
Bryan, Garnier & Co.
Societe Generale
Liberum Capital
ODDO BHF
BANK OF AMERICA (BOFA)	Sachin Jain